pimagedine has been researched along with Heart Disease, Ischemic in 9 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of ventricular tachycardia was reduced from 75% to 25% (P<0." | 1.30 | Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion. ( György, K; Papp, JG; Parratt, JR; Rastegar, MA; Végh, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinzel, FR | 1 |
| Gres, P | 1 |
| Boengler, K | 1 |
| Duschin, A | 1 |
| Konietzka, I | 1 |
| Rassaf, T | 1 |
| Snedovskaya, J | 1 |
| Meyer, S | 1 |
| Skyschally, A | 1 |
| Kelm, M | 1 |
| Heusch, G | 1 |
| Schulz, R | 1 |
| Wang, YP | 1 |
| Sato, C | 1 |
| Mizoguchi, K | 2 |
| Yamashita, Y | 1 |
| Oe, M | 2 |
| Maeta, H | 2 |
| Ding, HL | 1 |
| Zhu, HF | 1 |
| Dong, JW | 1 |
| Zhu, WZ | 1 |
| Yang, WW | 1 |
| Yang, HT | 1 |
| Zhou, ZN | 1 |
| Das, DK | 2 |
| Kalfin, R | 1 |
| Maulik, N | 2 |
| Engelman, RM | 1 |
| Matoba, S | 1 |
| Tatsumi, T | 1 |
| Keira, N | 1 |
| Kawahara, A | 1 |
| Akashi, K | 1 |
| Kobara, M | 1 |
| Asayama, J | 1 |
| Nakagawa, M | 1 |
| Végh, A | 1 |
| György, K | 1 |
| Rastegar, MA | 1 |
| Papp, JG | 1 |
| Parratt, JR | 1 |
| Lecour, S | 1 |
| Maupoil, V | 1 |
| Zeller, M | 1 |
| Laubriet, A | 1 |
| Briot, T | 1 |
| Rochette, L | 1 |
| Wang, Y | 1 |
| Xu, H | 1 |
| Hattori, R | 1 |
| Otani, H | 1 |
9 other studies available for pimagedine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs.
Topics: Acute Disease; Animals; Arginine; Calcium; Enzyme Inhibitors; Gene Expression Regulation, Enzymologi | 2008 |
Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase.
Topics: Analysis of Variance; Animals; Blotting, Western; Dexamethasone; Enzyme Activation; Enzyme Inhibitor | 2002 |
Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury.
Topics: Animals; Guanidines; Hypoxia; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion | 2005 |
Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection.
Topics: Animals; Arginine; Cardiotonic Agents; Enzyme Inhibitors; Guanidines; Heart; In Vitro Techniques; Mo | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti | 1999 |
Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Vessels | 1999 |
Levels of nitric oxide in the heart after experimental myocardial ischemia.
Topics: Animals; Chelating Agents; Coronary Vessels; Electron Spin Resonance Spectroscopy; Guanidines; Hemog | 2001 |
Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase.
Topics: Analysis of Variance; Animals; Enzyme Inhibitors; Guanidines; Intestinal Mucosa; Intestines; Ischemi | 2001 |
Pharmacological preconditioning with resveratrol: role of nitric oxide.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart Ventricles; Ischemic Preco | 2002 |